Hayleigh Collins | executive |
Sean Nolan | executive |
Sukumar Nagendran | executive |
Kamran Alam | executive |
Whitney Ijem | analyst |
Kristen Kluska | analyst |
Elizabeth Webster | analyst |
Gil Blum | analyst |
Yanan Zhu | analyst |
Jack Allen | analyst |
Mehdi Goudarzi | analyst |
Silvan Tuerkcan | analyst |
Good afternoon, and welcome to the Taysha Gene Therapies Third Quarter 2023 Earnings Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions]Please note that this call is being recorded.I'd now like to turn the call over to Hayleigh Collins, the Director, Head of Corporate Communications and Investor Relations. Thank you, and you may proceed, Hayleigh.
Thank you.